Stay updated on PTI-125 in Alzheimer's Patients Clinical Trial
Sign up to get notified when there's something new on the PTI-125 in Alzheimer's Patients Clinical Trial page.

Latest updates to the PTI-125 in Alzheimer's Patients Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error instead of the study results.SummaryDifference0.2%

- Check12 days agoChange DetectedA banner announces NIH website updates and FAQs about using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during a transition.SummaryDifference1%

- Check19 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 on the error page.SummaryDifference0.2%

- Check26 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1; the study page still displays a 403 error.SummaryDifference0.2%

- Check33 days agoChange DetectedThe study page displays a 403 Forbidden error with a Home link instead of study information.SummaryDifference0.5%

- Check47 days agoChange DetectedThe page now displays a 403 Forbidden error message with a minimal header and navigation, replacing the usual study results content with an access-denied state.SummaryDifference21%

Stay in the know with updates to PTI-125 in Alzheimer's Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PTI-125 in Alzheimer's Patients Clinical Trial page.